4:11 PM ET
Form 4
Insider Selling
Avalo Therapeutics CFO Christopher Ryan Sullivan Sells $202K of Stock
Christopher Ryan Sullivan, CFO, sold 12,394 shares of Avalo Therapeutics, Inc. at $16.33 a share, worth $202K in total on Sep 16, 2026. Shares held after the trade: 39,900 (-23.7%).
- Value
- $202K
- Shares
- 12,394
- Price
- $16.33
- Role
- CFO
- Holding change
- -23.7%
- Trade date
- Sep 16, 2026